Department of Health and Social Care

The statutory regulation of healthcare professionals in the United Kingdom is designed to protect patients and the public by ensuring that registered practitioners are appropriately trained, competent, and fit to practise.

The UK’s healthcare professional regulators are independent bodies responsible for setting standards of education, training, and professional conduct. They are also responsible for setting registration routes, including for overseas‑qualified applicants, to ensure UK standards of safe and effective practice are met. Only those who meet these requirements can legally practise in regulated healthcare professions.

National Health Service employers are responsible for ensuring that individuals appointed to specific roles meet the requirements of those posts in line with service needs, patient safety requirements, and relevant NHS frameworks.

The Government is committed to maintaining robust regulatory frameworks that support public safety, professional standards, and confidence in the healthcare system. Through its programme of regulatory reform, the Government will bring forward legislation to modernise the legislative frameworks of the regulators to ensure that they have the powers they require to protect the public while supporting an effective and flexible workforce. In the meantime, we continue to engage with regulators to support the effective use of their existing powers and frameworks to facilitate efficient registration pathways for both UK and overseas‑qualified applicants, consistent with public protection.

The 10 Year Workforce Plan will set out how the Government will ensure the NHS has the right people, in the right places, with the right skills to care for patients when they need it.

The removal of the councils of governors from National Health Service foundation trusts (FTs) forms part of the wider 10-Year Health Plan’s aim to ensure hospitals put patient experiences and outcomes at the heart of their decision-making. This will require primary legislation, which the Government will bring forward when parliamentary time allows, and the will of Parliament. Until then, FT governors will remain in post with their statutory powers unchanged.

While governors have provided helpful advice and oversight for some FTs, we now need to move to a more dynamic model, drawing on patient, staff, and stakeholder insight. For example, approaches to engagement that better reflect local demographics and geography rather than a ‘one size fits all’ governor model, as well as supporting an increased focus on the outcomes of the engagement, including the evidence that local people are involved in key decisions about how care is provided and their voices are listened to.

The removal of the councils of governors from National Health Service foundation trusts (FTs) forms part of the wider 10-Year Health Plan’s aim to ensure hospitals put patient experiences and outcomes at the heart of their decision-making. This will require primary legislation, which the Government will bring forward when parliamentary time allows, and the will of Parliament. Until then, FT governors will remain in post with their statutory powers unchanged.

While governors have provided helpful advice and oversight for some FTs, we now need to move to a more dynamic model, drawing on patient, staff, and stakeholder insight. For example, approaches to engagement that better reflect local demographics and geography rather than a ‘one size fits all’ governor model, as well as supporting an increased focus on the outcomes of the engagement, including the evidence that local people are involved in key decisions about how care is provided and their voices are listened to.

NHS England has not undertaken a formal national assessment of regional variation in access to left atrial appendage occlusion (LAAO).

LAAO is a prescribed specialised service and is commissioned in accordance with NHS England’s published national clinical commissioning policy, with further information available at the following link:

https://www.england.nhs.uk/publication/clinical-commissioning-policy-left-atrial-appendage-occlusion-for-patients-with-atrial-fibrillation-and-relative-or-absolute-contraindications-to-anticoagulation-adults/

NHS England’s regional specialised commissioners and integrated care boards are responsible for the monitoring of activity, the reviewing of equity of access for their populations, and for addressing variation through local oversight and clinical networks.

NHS England publishes monthly information on the composition of the workforce employed by National Health Service trusts and integrated care boards in England. This includes information on the workforce employed by individual bodies and for high-level staffing groups. The information can be found at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics

No specific central assessment has been made of the workforce capacity of women’s health services in the region, with decisions on the provision of local services being managed by individual NHS service provider and commissioners.

The Government acknowledges the challenges faced by women with endometriosis and the impact it has on their lives, their relationships, and their participation in education and the workforce. We are committed to improving the diagnosis, treatment, and ongoing care for endometriosis. It is unacceptable that women can wait so long for an endometriosis diagnosis and we are taking action to address this.

Nationally, we are establishing an “online hospital”, NHS Online, which will give people across the country, on certain pathways, the choice of getting the specialist care they need from their home. It will connect patients with clinicians across the country through secure, online appointments accessed through the NHS App.

Menstrual problems, which may be a sign of endometriosis, will be among the first nine conditions available for referral to NHS Online from 2027. We’ve chosen some of the conditions with the longest waits and where online consultation works best. NHS Online will help to reduce patient waiting times, delivering the equivalent of up to 8.5 million appointments and assessments in its first three years, four times more than an average trust, while enhancing patient choice and control over their care. This will allow women with menstrual problems which may be a sign of endometriosis across the country to reach a diagnosis and explore treatment options sooner.

Buckinghamshire delivers specialist gynaecology care to women through both community and secondary care, or hospital, services, with community services delivered from general practices across the county, including in Aylesbury. To further improve access to women's health services, the Buckinghamshire Healthcare Trust is working to expand community services, increasing clinic sites, and aligning to neighbourhoods including North Bucks, to ensure more women can be seen for specialist gynaecology care more quickly and closer to home in the community service, thereby increasing capacity within the secondary care service to support waiting list reductions.

As set out in the 10-Year Health Plan, the Government has committed to create a new model of care, fit for the future. In spring we will publish a 10 Year Workforce Plan to create a workforce ready to deliver that transformed service.

The 10 Year Workforce Plan has been developed and is informed by regular discussions with NHS England and will ensure the National Health Service has the right people in the right places, with the right skills to care for patients when they need it. We are working through how the plan will articulate changes for different professional groups.

NHS England routinely publishes information on postponed inpatient and outpatient appointments during periods of industrial action, and this information will be published in due course. Further information will be available at the following link:

https://www.england.nhs.uk/publication/preparedness-for-potential-industrial-action-in-the-nhs/#heading-3

Indicative Activity Plans (IAPs) are non-binding, forecasted schedules under the NHS Standard Contract that define expected service volumes between commissioners for integrated care boards (ICBs) and providers. In setting these volumes, ICBs and providers are responsible for ensuring they do so with fairness and transparency.

ICBs have contractual powers to manage activity by providers, which were enhanced in 2025/26 with central support for setting and managing activity. The NHS Standard Contract includes the ability to set IAPs to help providers and commissioners plan demand, capacity, and expenditure. While not binding, if activity exceeds, or falls short of the agreed plan, and therefore the funding agreed, an Activity Management Plan can be agreed to bring activity back in line.

Integrated care boards (ICBs) plan, commission, and oversee the provision of local National Health Services, including community health services, to meet their population’s needs.

The Government is committed to training the staff we need to ensure patients are cared for by the right professional, when and where they need it. We will publish a 10 Year Workforce Plan to set out action to create a workforce ready to deliver the transformed services set out in the 10-Year Health Plan.

We know people are waiting too long for community health services. That is why, for the first time, we have set a clear target for systems to work to reduce long waits in NHS England’s Medium-Term Planning Framework.

By 2028/29 at least 80% of community health services activity should take place within 18 weeks, bringing community health services in line with targets for elective care.

In 2025, we published, for the first time, an overview of the core community health services, Standardising Community Health Services, that ICBs should consider when planning for their local populations to support improved commissioning and delivery of community health services, a vital part of Neighbourhood Health. Further guidance was published in February 2026, providing more detailed descriptions of the core components of community health services for ICBs.

Integrated care boards (ICBs) have the flexibility to commission services across specialties within a fixed financial envelope and may use contract levers to manage that activity. This represents good management of public money to achieve the outcomes we want to see.

Patients have a legal right to choose any qualified provider holding a contract with an ICB to deliver the services patients need. This right applies irrespective of levels of activity outlined in indicative activity plans contained in contracts.

The Department does not centrally hold data on workforce capacity for allied health professions supporting prevention and community healthcare services in England by profession.

NHS England published monthly data drawn from the Electronic Staff Record, the Human Resources system for the National Health Service, on the number of staff employed in the NHS in England, which is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics

This information can be used to identify the number of individual allied health professionals employed but is not able to robustly identify the specific service or setting in which staff are delivering care.

The Government is committed to training the staff we need to ensure patients are cared for by the right professional, when and where they need it. We will publish a 10 Year Workforce Plan to set out action to create a workforce ready to deliver the transformed services set out in the 10-Year Health Plan.

Independent sector providers are commissioned and managed by integrated care boards (ICBs) under the terms of the NHS Standard Contract which applies the same standards of oversight and regulation as are applied to National Health Service providers.

In the 10-Year Health Plan for England, we set out we would not tolerate ‘gaming’ the national payment tariff to cherry pick the simplest, most profitable cases. ICBs are expected to monitor this, and act decisively where they identify problems as part of a wider duty to safeguard and ensure value for taxpayer money.

Non-Emergency Patient Transport Schemes (NEPTS) often provide funded transport where a medical condition means that a patient would struggle to safely attend their treatment independently.  NEPTS can be provided by ambulance trusts or other providers depending on local arrangements.

In May 2022, NHS England set out eligibility criteria, which includes disability criteria, available at the following link:

https://www.england.nhs.uk/wp-content/uploads/2022/05/B1244-nepts-eligibility-criteria.pdf

NHS England has worked closely with a range of kidney patient groups, renal professionals, integrated care boards (ICBs), and other stakeholders to develop a dialysis transport support framework which has been made directly available to ICBs. The 2022 updates to the eligibility criteria included where patients are travelling to or returning from in-centre haemodialysis, in which case specialist transport, non-specialist transport, or upfront/reimbursement costs for private travel will be made available.

NEPTS in England is an operational matter for the National Health Service, and how the NEPTS guidance is implemented at a local level is determined by ICBs and their partners, including local ambulance trusts. There are no current plans to update the eligibility criteria further.

Non-Emergency Patient Transport Schemes (NEPTS) often provide funded transport where a medical condition means that a patient would struggle to safely attend their treatment independently.  NEPTS can be provided by ambulance trusts or other providers depending on local arrangements.

In May 2022, NHS England set out eligibility criteria, which includes disability criteria, available at the following link:

https://www.england.nhs.uk/wp-content/uploads/2022/05/B1244-nepts-eligibility-criteria.pdf

NHS England has worked closely with a range of kidney patient groups, renal professionals, integrated care boards (ICBs), and other stakeholders to develop a dialysis transport support framework which has been made directly available to ICBs. The 2022 updates to the eligibility criteria included where patients are travelling to or returning from in-centre haemodialysis, in which case specialist transport, non-specialist transport, or upfront/reimbursement costs for private travel will be made available.

NEPTS in England is an operational matter for the National Health Service, and how the NEPTS guidance is implemented at a local level is determined by ICBs and their partners, including local ambulance trusts. There are no current plans to update the eligibility criteria further.

Data is available for emergency finished admission episodes (FAEs) where there was a primary diagnosis of 'respiratory conditions’. The following table shows the number of FAEs where there was a primary diagnosis of 'respiratory conditions’ for North Cornwall and England, for activity in English National Health Service hospitals and English NHS-commissioned activity in the independent sector, for 2024/25 and provisionally for 2025/26:

Source: Hospital Episode Statistics, NHS England.

Available data on trends in respiratory conditions can be found on the Department’s Fingertips dataset. Data is not available by parliamentary constituency. Data is available at regional, county, unitary authority, and integrated care board level. Information for Cornwall is available at the following link:

https://fingertips.phe.org.uk/search/Respiratory#page/1/gid/1/pat/15/ati/502/are/E06000052/iid/90933/age/314/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

The Department has made no formal estimate of the cost of missed appointments in Warwickshire or nationally.

However, we’re clear that reducing missed appointments is an important part of improving elective care and making best use of National Health Service capacity to cut waiting times. The Government has committed, in the Elective Reform Plan, to focussed action to reduce missed appointments, including enhancing two-way communication between hospitals and patients, and to use artificial intelligence to predict who will miss appointments, to save up to one million missed appointments. NHS England continues to support the validation of waiting lists, as part of the Government's plans for a more productive and improved approach to elective care which is better for patients. Effective validation helps trusts to understand the true size of their waiting list for better planning and can help avoid missed appointments to reduce overall waiting times.

Locally, trusts are also using data‑led approaches to prioritise proactive appointment reminders, making greater use of the NHS App and patient portals, and targeting specialties with higher non‑attendance rates through outpatient improvement work.

NHS England invests approximately £1 billion per year centrally to operate, support, and upgrade nationally managed technology systems, including the NHS App and core data services.

In addition, over the current Spending Review period, NHS England plans to invest approximately £2 billion with care provider organisations through the Frontline Productivity Programme, supporting the use of technology to improve productivity and make better use of existing digital infrastructure. This includes targeted investment where providers choose to converge on common platforms to support local system working and the priorities of the 10‑Year Health Plan.

Funding allocations for technology investment by individual integrated care boards and local systems will be determined by NHS England regions and systems in due course, in line with local priorities and national guidance.

We have no funding allocated specifically to local authorities to update their legacy social care systems, and responsibility for procuring and updating their own systems lies with them.

The Department has not made a central estimate of the level of savings to National Health Services in Norfolk specifically arising from programmes delivered by the voluntary, community, and social enterprise (VCSE) sector.

VCSE organisations play an important role in supporting prevention, early intervention, and community-based care, which can help improve outcomes for patients and reduce pressure on statutory services.

Funding decisions for health services in England are made by integrated care boards (ICBs) and are based on the clinical needs of their local population.

On 31 March, the National Institute for Health and Care Excellence (NICE) published its updated fertility guideline, which recommends that women under 40 years old who meet the clinical eligibility criteria should be offered up to three full cycles of in vitro fertilisation (IVF).

There are no plans to introduce statutory duties on ICBs to deliver NICE fertility guidelines on IVF cycles. We expect ICBs to consider and reflect the updated NICE fertility guideline in their commissioning decisions, and we are working with NHS England to support greater consistency in provision.

The Government published the Women's Health Strategy on 15 April which commits to ensuring that every woman can easily access fertility services, and we are currently working to assess the current provision of National Health Service commissioned fertility services as a baseline to inform supporting material for every ICB to implement the new NICE guidelines in full.

Funding decisions for health services in England are made by integrated care boards (ICBs) and are based on the clinical needs of their local population.

On 31 March, the National Institute for Health and Care Excellence (NICE) published its updated fertility guideline, which recommends that women under 40 years old who meet the clinical eligibility criteria should be offered up to three full cycles of in vitro fertilisation (IVF).

There are no plans to introduce statutory duties on ICBs to deliver NICE fertility guidelines on IVF cycles. We expect ICBs to consider and reflect the updated NICE fertility guideline in their commissioning decisions, and we are working with NHS England to support greater consistency in provision.

The Government published the Women's Health Strategy on 15 April which commits to ensuring that every woman can easily access fertility services, and we are currently working to assess the current provision of National Health Service commissioned fertility services as a baseline to inform supporting material for every ICB to implement the new NICE guidelines in full.

NHS England continues to support the improvement of stroke pathways through Integrated Stroke Delivery Networks, including strengthening pre-hospital triage, inter-hospital transfer pathways, and emergency referral arrangements.

These actions are intended to reduce unwarranted variation and improve equitable access to mechanical thrombectomy for stroke patients, including those living in rural areas such as Somerset, while ensuring services remain clinically safe and sustainable.

Mechanical thrombectomy is an evidence-based treatment for eligible patients with large vessel occlusion stroke and is recognised as a national clinical priority.

The service is commissioned by NHS England as a specialised service, with aspects of planning and delivery supported locally through specialised commissioning delegated arrangements, working closely with integrated care boards and systems.

NHS England has assessed the need to improve access to mechanical thrombectomy through national clinical policy, audit, and service monitoring. NHS England routinely monitors access and outcomes through the Sentinel Stroke National Audit Programme, which has demonstrated variation in access across England, including challenges related to geography and travel times.

In response to this assessed need, work continues to develop and strengthen services. In addition to NHS England’s aforementioned improvement of stroke pathways through Integrated Stroke Delivery Networks, work is also ongoing to support the expansion and sustainability of thrombectomy capable services where clinically and operationally appropriate, within the framework of specialised commissioning delegated services. For instance, 24/7 services to serve stroke patients are available at Bristol and Plymouth.

The Renewed Women’s Health Strategy was published on 15 April 2026 and women’s access to care is a key theme. We will support integrated care board to introduce a single point of access for all non-urgent referrals to gynaecology and women's health services to speed up access to better treatment

We will redesign clinical pathways for the most common pathways including heavy periods, menopause, and uro-gynaecology. This will standardise care pathways and remove unnecessary procedural delays.

We will fund a specialist centre in each region for group-based approaches to high volume low complexity women’s health pathways. This will improve productivity and empower women in common clinical areas, helping to reduce waiting lists and supporting self-management.

We will accelerate the deployment and spread of innovations that benefit women’s health, launching a FemTech healthcare challenge within two years with a pot of £1.5 million.

Funded by £5.25 million, we will expand access to Musculoskeletal (MSK) Hubs in the community by leveraging the leisure and fitness workforce to deliver evidence-based physical activity for people with MSK conditions.

Buckinghamshire delivers specialist gynaecology care to women through both community and secondary care, or hospital, services, with community services delivered from general practices across the county, including in Aylesbury. To further improve access to women's health services, the Buckinghamshire Healthcare Trust and FedBucks are working together to expand community services, increasing clinic sites and aligning to neighbourhoods including North Bucks, to ensure more women can be seen for specialist gynaecology care more quickly and closer to home in the community service, thereby increasing capacity within the secondary care service to support waiting list reductions.

A women's health data dashboard is available on the NHS Futures website and is available to anyone working within health and care sector who requires insight into women's health.

The dashboard is intended to provide national and local insight into the key aims of women's health aligned with the priorities of NHS England’s Women’s Health Programme and highlight potential unmet need, unwarranted variation, and health inequalities.

The Government will make the data dashboard publicly available with the next year, as set out in the Renewed Women’s Health Strategy published on 15 April 2026.

The Government acknowledges the importance of ensuring healthcare professionals are adequately trained and educated on women’s health conditions, including endometriosis, and we have taken action to address this.

The standard of undergraduate medical training is the responsibility of the General Medical Council (GMC), the independent regulator of the medical profession, which set the outcomes and standards expected at undergraduate level. Medical schools are responsible for their curricula. The delivery of these undergraduate curricula must meet the standards set by the GMC, who then monitor and check to make sure that these standards are maintained.

The curriculum for specialty training is set by individual royal colleges and faculties. The GMC approves curricula and assessment systems for each training programme. Curricula emphasise the skills and approaches that a doctor must develop to ensure accurate and timely diagnoses and treatment plans for their patients.

The Royal College of General Practitioners (RCGP) is responsible for publishing the postgraduate curriculum for general practitioners (GPs) and ensuring it remains up to date. The RCGP curriculum covers endometriosis as part of its gynaecology and breast health module.

GPs are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. The RCGP has worked with partners, including Endometriosis UK, to develop educational resources relating to endometriosis to support GPs and other healthcare professionals to deliver the best possible care for women, based on the latest evidence.

NHS England made the decision in 2025 to discontinue central funding of the salary support component of the Training Interface Group programme, and to target financial resources more effectively to address regional workforce priorities. Regions or provider organisations that wish to continue developing these skills are still able to recruit, fund, and train staff using the curriculum set by the Joint Committee on Surgical Training.

NHS England is also working to understand where they can enhance and support smaller, highly specialised areas of practice.

NHS England has initiated a plan, working with clinical subject matter experts, to define the demand and future supply needed for the training of cleft lip and palate surgeons and to shape the future training and workforce investment needed in this area.

We are significantly expanding urgent care across the country, including building and expanding 40 same day emergency care services and urgent treatment centres. This will mean patients are treated more quickly and in the most appropriate setting, while easing pressure on busy accident and emergency departments so they can focus on the most serious cases.

Alongside this, we are expanding urgent care outside hospital through new neighbourhood health services. Urgent community care enables people to receive timely, high‑quality care in their own homes or communities, helping to maintain independence and ensuring hospital attendance only where clinically necessary. The Neighbourhood Health model prioritises urgent community response, virtual wards, and coordinated multidisciplinary teams to support people with escalating or acute needs, preventing unnecessary hospital admissions and supporting care closer to home.

The Urgent and Emergency Care Delivery Plan 2025/26 also committed to scaling a new “Home First” approach, enabling ambulance services to prioritise the most critical cases while providing alternative pathways for those with less urgent needs. This includes “see and treat” and “hear and treat” approaches, supported by additional clinicians in emergency operations centres and single points of access.

The Young People and Work independent investigation, led by Alan Milburn, considers the drivers of the rise in young people who are out of employment, education, and training (NEET). Increased reporting of ill health as a primary reason for being NEET among young people since 2015 is driven primarily by mental health and neurodevelopmental conditions.

The Independent Review into Mental Health Conditions, ADHD and Autism has been investigating changes in the diagnosis of these conditions and will be cross-referenced in the forthcoming first report of the Young People and Work review. The two reviews will need to continue to work together to consider the effects of under-diagnosis on employment and educational outcomes.

The Independent Review into Mental Health Conditions, ADHD and Autism is examining changes in population prevalence, levels of psychological distress, recorded diagnosis and referral, and perceived need for support. A key aim of the review is to understand how these relate to one another. The review is also considering how current support systems work in practice. This includes whether diagnosis has too often become the only gateway to help, and how earlier intervention and preventative support are best offered within and beyond the National Health Service. The review is independent of the Government, and it is for the chair and vice chairs to determine the specific issues the review considers.

The review’s interim report, published at the end of March, sets out the evidence reviewed so far on prevalence, describes the impact of rising demand for diagnosis and support, identifies where the evidence is uncertain, and outlines the key questions for the next phase. It does not offer final conclusions or recommendations.

The final report, due in the summer, will make recommendations on how the Government, the health system, and wider public services can respond to increasing demand for support more fairly and effectively so that people receive the right support, at the right time, in the right place.

A central concern of the review is that access to recognition, diagnosis, and support is uneven. The next phase will examine inequalities in prevalence, diagnosis, support, and outcomes in more detail, including variation by ethnicity, age, sex, deprivation, and other characteristics.

The Independent Review into Mental Health Conditions, ADHD and Autism is examining changes in population prevalence, levels of psychological distress, recorded diagnosis and referral, and perceived need for support. A key aim of the review is to understand how these relate to one another. The review is also considering how current support systems work in practice. This includes whether diagnosis has too often become the only gateway to help, and how earlier intervention and preventative support are best offered within and beyond the National Health Service. The review is independent of the Government, and it is for the chair and vice chairs to determine the specific issues the review considers.

The review’s interim report, published at the end of March, sets out the evidence reviewed so far on prevalence, describes the impact of rising demand for diagnosis and support, identifies where the evidence is uncertain, and outlines the key questions for the next phase. It does not offer final conclusions or recommendations.

The final report, due in the summer, will make recommendations on how the Government, the health system, and wider public services can respond to increasing demand for support more fairly and effectively so that people receive the right support, at the right time, in the right place.

A central concern of the review is that access to recognition, diagnosis, and support is uneven. The next phase will examine inequalities in prevalence, diagnosis, support, and outcomes in more detail, including variation by ethnicity, age, sex, deprivation, and other characteristics.

The Independent Review into Mental Health Conditions, ADHD and Autism is examining changes in population prevalence, levels of psychological distress, recorded diagnosis and referral, and perceived need for support. A key aim of the review is to understand how these relate to one another. The review is also considering how current support systems work in practice. This includes whether diagnosis has too often become the only gateway to help, and how earlier intervention and preventative support are best offered within and beyond the National Health Service. The review is independent of the Government, and it is for the chair and vice chairs to determine the specific issues the review considers.

The review’s interim report, published at the end of March, sets out the evidence reviewed so far on prevalence, describes the impact of rising demand for diagnosis and support, identifies where the evidence is uncertain, and outlines the key questions for the next phase. It does not offer final conclusions or recommendations.

The final report, due in the summer, will make recommendations on how the Government, the health system, and wider public services can respond to increasing demand for support more fairly and effectively so that people receive the right support, at the right time, in the right place.

A central concern of the review is that access to recognition, diagnosis, and support is uneven. The next phase will examine inequalities in prevalence, diagnosis, support, and outcomes in more detail, including variation by ethnicity, age, sex, deprivation, and other characteristics.

The Cancer Vaccine Launch Pad (CVLP) is a platform that is increasing access and speeding up recruitment to clinical trials for personalised cancer vaccines and other immunotherapies for patients who have been diagnosed with cancer. In 2025, the scope of the CVLP was expanded beyond personalised cancer vaccines to also include other immunotherapies. NHS England is responsible for the overall delivery of the CVLP and has contracted the Southampton Clinical Trials Unit to manage the day-to-day delivery of the platform.

The platform is designed to be company and clinical trial agnostic so any company can contact the CVLP to explore how the platform can support their research. NHS England hosted a webinar with interested pharmaceutical companies in 2025 after the expansion of the scope had been agreed, and continues to engage with companies through multiple avenues, including working with the National Institute for Health and Care Research and the Vaccine Innovation Pathway.

The National Institute of Health and Care Excellence (NICE) is an independent body and is responsible for making decisions on whether its published guidelines should be updated in light of new evidence or emerging issues not in the scope of the original guideline. NICE maintains surveillance of new evidence that may affect its published guidance, and decisions on whether guidelines should be updated are taken by a prioritisation board chaired by its Chief Medical Officer.

NICE has no current plans to update the guidance it has issued on Suspected cancer: recognition and referral, code NG12, or to introduce a standalone clinical rule for suspected bowel cancer, including for patients under 50 years old, to allow timely referral for further investigation and a second opinion at first presentation.

The Government is committed to delivering digital services that are accessible to all patients and has established a national change programme to ensure the NHS App is accessible to the whole population by 2028, including those who do not routinely use smartphones.

As part of its 10-Year Health Plan, the Government has tasked National Health Service integrated care boards and providers with mitigating any digital exclusion through operational guidance, proactively offering NHS App communications while maintaining high quality non-digital options such as letters, phone, and face to face contact.

Furthermore, the NHS App is co-designed and tested with people from deprived and inclusion groups, including blind and visually impaired users, as well as people with low digital confidence.

Practical support is being expanded through public libraries, where NHS App guidance and staff support are provided, alongside training for frontline NHS staff and an NHS App Ambassadors programme that runs sessions in general practices, libraries, and community centres across England. Of course, the NHS App is also accessible through the NHS website.

I refer the hon. Member to the answer I gave on 22 April 2026 to Question 115339.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Where there is no pharmacologically relevant animal species for testing a biological product, the position of the Medicines and Healthcare products Regulatory Agency (MHRA) is that there should be no studies done on animals, and in March 2026, the MHRA published a statement on its website that included this text: “For certain drug substances that are not pharmacologically active in animals, the MHRA does not support testing in animals (including with surrogate molecules). For this group of drugs, non-animal-based methods suffice to support expectations for efficacy and safety in clinical development”. This position is represented to companies that seek scientific advice from the MHRA on drug development in this context. Further information is available at the following two links:

https://www.gov.uk/government/publications/replacing-animals-in-science-strategy/replacing-animals-in-science-a-strategy-to-support-the-development-validation-and-uptake-of-alternative-methods

https://www.gov.uk/guidance/mhra-approach-to-medicines-using-non-animal-methods

Non‑direct altruistic organ donation is managed by NHS Blood and Transplant, which is responsible for organ donation services. Non‑direct altruistic donation involves people donating an organ, such as a kidney or a lobe of liver, as a living donor without knowing the recipient or expecting anything in return. The following table shows the number of non-direct altruistic donations across the United Kingdom, split by organ, namely kidney or liver:

Source: NHS Blood and Transplant, using data from the UK Transplant Registry.

For every financial year since 2016/17, there has been five or less non-direct altruistic liver lobe donations. There has been a total of 14 non-direct altruistic liver lobe donations in the past ten years.

The Department has regular discussions with the General Optical Council (GOC) on regulatory matters.

While the GOC is an independent regulator responsible for managing its fitness to practise processes, the Government expects the GOC to take steps to improve the efficiency and timeliness of case handling.

In March 2026, the Professional Standards Authority (PSA) published its 2024/25 performance review of the GOC, concluding that that it met all 18 Standards of Good Regulation, including those relating to fitness to practise. The PSA found that most fitness to practise investigations were timely and adequate, with risks managed appropriately. However, the PSA identified some areas for improvement which the GOC is addressing through an action plan. The PSA will monitor the progress of this plan as part of its continuous oversight of GOC’s performance.

In parallel, the Department is progressing wider, longer-term reforms to the regulatory frameworks of the healthcare professional regulators. These will enable them to be more responsive to changes in the health and care workforce and give them the flexibility to modernise their fitness to practise processes whilst maintaining public protection.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.